Brief: Shenzhen Hepalink Pharmaceutical Says Unit Entered Distribution & Supply Deal
03/04/2023 11:28
April 3 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd 002399.SZ :
* ON MARCH 30 UNIT ENTERED DISTRIBUTION & SUPPLY AGREEMENT
WITH
CHIA TAI TIANQING PHARMACEUTICAL
* CTTQ TO GRANT TO TECHDOW USA LICENSE TO COMMERCIALIZE
FOSAPREPITANT DIMEGLUTIDE IN UNITED STATES
Source text for Eikon: ID:nHKSbCDsWY
Further company coverage: 002399.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA